116 related articles for article (PubMed ID: 15979704)
1. Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin.
Ravandi F; Faderl S
Leuk Res; 2006 Jan; 30(1):103-5. PubMed ID: 15979704
[TBL] [Abstract][Full Text] [Related]
2. [A case of effective use of alemtuzumab in a male patient with T-cell lymphoma].
Sokolov AH; Parovichnikova EN; Isaev VG; Ustinova EN; Shavlokhov VS; Atopkov VA; Model SV; Tsyba NN; Kaplanskaia IB; Kliasova GA; Aleksanian MZh; Vishnevskaia ES; Togonidze DK; Mirzoian EE; Savchenko VG
Ter Arkh; 2004; 76(12):73-5. PubMed ID: 15724932
[No Abstract] [Full Text] [Related]
3. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Mone A; Puhalla S; Whitman S; Baiocchi RA; Cruz J; Vukosavljevic T; Banks A; Eisenbeis CF; Byrd JC; Caligiuri MA; Porcu P
Blood; 2005 Nov; 106(10):3380-2. PubMed ID: 16076875
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.
Ravandi F; Aribi A; O'Brien S; Faderl S; Jones D; Ferrajoli A; Huang X; York S; Pierce S; Wierda W; Kontoyiannis D; Verstovsek S; Pro B; Fayad L; Keating M; Kantarjian H
J Clin Oncol; 2009 Nov; 27(32):5425-30. PubMed ID: 19805674
[TBL] [Abstract][Full Text] [Related]
5. Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
Zinzani PL; Alinari L; Tani M; Fina M; Pileri S; Baccarani M
Haematologica; 2005 May; 90(5):702-3. PubMed ID: 15921394
[TBL] [Abstract][Full Text] [Related]
6. Pentostatin treatment combinations in chronic lymphocytic leukemia.
Lamanna N; Kay NE
Clin Adv Hematol Oncol; 2009 Jun; 7(6):386-92. PubMed ID: 19606074
[TBL] [Abstract][Full Text] [Related]
7. The role of alemtuzumab in the management of T-cell malignancies.
Dearden C
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S44-52. PubMed ID: 16720203
[TBL] [Abstract][Full Text] [Related]
8. A psoriasiform rash.
Patalay R; Fields P; Kazmi M; Francis ND; Bunker CB
Clin Exp Dermatol; 2010 Mar; 35(2):209-10. PubMed ID: 20447087
[No Abstract] [Full Text] [Related]
9. Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Vazquez ER; Spigel DR; Raefsky E; Bearden JD; Saez RA; Greco FA
Cancer; 2008 Mar; 112(6):1288-95. PubMed ID: 18189296
[TBL] [Abstract][Full Text] [Related]
10. Large granular lymphocyte leukemia: natural history and response to treatment.
Fortune AF; Kelly K; Sargent J; O'Brien D; Quinn F; Chadwick N; Flynn C; Conneally E; Browne P; Crotty GM; Thornton P; Vandenberghe E
Leuk Lymphoma; 2010 May; 51(5):839-45. PubMed ID: 20367569
[TBL] [Abstract][Full Text] [Related]
11. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Hale G; Slavin S; Goldman JM; Mackinnon S; Giralt S; Waldmann H
Bone Marrow Transplant; 2002 Dec; 30(12):797-804. PubMed ID: 12476271
[TBL] [Abstract][Full Text] [Related]
13. T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Aribi A; Huh Y; Keating M; O'brien S; Ferrajoli A; Faderl S; Wierda W; Kantarjian H; Ravandi F
Leuk Res; 2007 Jul; 31(7):939-45. PubMed ID: 17045649
[TBL] [Abstract][Full Text] [Related]
14. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Mittal S; Milner BJ; Johnston PW; Culligan DJ
Eur J Haematol; 2006 Jun; 76(6):531-4. PubMed ID: 16548918
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia.
Gómez-Almaguer D; Jaime-Pérez JC; Garza-Rodríguez V; Chapa-Rodríguez A; Tarín-Arzaga L; Herrera-Garza JL; Ruiz-Argüelles GJ; López-Otero A; González-Llano O; Rodríguez-Romo L
Ann Hematol; 2010 Mar; 89(3):299-303. PubMed ID: 19705116
[TBL] [Abstract][Full Text] [Related]
16. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D
Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250
[TBL] [Abstract][Full Text] [Related]
17. Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
Wendtner CM; Ritgen M; Schweighofer CD; Fingerle-Rowson G; Campe H; Jäger G; Eichhorst B; Busch R; Diem H; Engert A; Stilgenbauer S; Döhner H; Kneba M; Emmerich B; Hallek M;
Leukemia; 2004 Jun; 18(6):1093-101. PubMed ID: 15071604
[TBL] [Abstract][Full Text] [Related]
18. Prolymphocytic leukemia.
Absi A; Hsi E; Kalaycio M
Curr Treat Options Oncol; 2005 May; 6(3):197-208. PubMed ID: 15869731
[TBL] [Abstract][Full Text] [Related]
19. Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
Orlandi EM; Baldanti F; Citro A; Pochintesta L; Gatti M; Lazzarino M
Haematologica; 2008 Nov; 93(11):1758-60. PubMed ID: 18790800
[No Abstract] [Full Text] [Related]
20. Alemtuzumab in chronic lymphocytic leukemia.
James DF; Kipps TJ
Future Oncol; 2007 Feb; 3(1):29-42. PubMed ID: 17280499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]